Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HEPATITIS B VIRUS SURFACE CONFIRMATORY ANTIGEN (HBSAG) - ANVISA Registration 10033121083

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE CONFIRMATORY ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10033121083 and manufactured by BECKMAN COULTER INC. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Aug 04, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTICS DIVISION, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10033121083
2 Related Devices
Registration Details
ANVISA Registration Number: 10033121083
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

10033121083

25351442291202436

42160812000144

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Aug 04, 2025

04/08/2035

09/18/2025 19:00:01

Registration Details

10033121083

25351442291202436

42160812000144

Dates and Status

Aug 04, 2025

04/08/2035

09/18/2025 19:00:01